— Funding to accelerate development and commercial launch of Proteograph™ suite of reagents, instrument and software products to deliver on untapped promise of proteomics — Redwood City, CA — Seer, Inc., a life sciences company focused on empowering exceptional scientific outcomes through the power of rapid, deep, unbiased proteomics information, today announced that it has raised […]

EMERYVILLE, Calif. — Berkeley Lights, Inc., (Nasdaq: BLI) a leader in Digital Cell Biology, today announced the closing of its initial public offering of 9,315,000 shares of common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 1,215,000 shares of common stock, at a public offering […]

EMERYVILLE, Calif., July 16, 2020 (GLOBE NEWSWIRE) — Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its initial public offering of 8,100,000 shares of common stock at a public offering price of $22.00 per share. All of the shares of common stock are being offered by Berkeley Lights. In addition, Berkeley Lights has granted the underwriters a […]

Venlo, the Netherlands  – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced that its shareholders today approved all agenda items at the Company’s Annual General Meeting related to the proposed voluntary public takeover offer for the acquisition of all ordinary shares in QIAGEN by Quebec B.V., a wholly-owned subsidiary of Thermo Fisher Scientific Inc. (NYSE: TMO) for EUR 39 per […]

This funding will be used to develop a compact, low-cost device for the autonomous monitoring of hazardous substances in high-risk settings, such as oil refining, power generation, and chemical manufacturing. FAYETTEVILLE, Ark. Zebra Analytix—a VIC Technology Venture Development portfolio company—announced today that it has received a Small Business Innovation Research (SBIR) grant from the National […]

Funding by CVC Credit Partners will support the business’s buy-and-build growth strategy CVC Credit Partners (“CVC Credit”) is pleased to announce that it has provided a $92 million multicurrency first lien credit facility to Calibre Scientific, the life sciences and diagnostics business owned by StoneCalibre. Funding provided by CVC Credit will be used to refinance […]

Rick Klausner, Bob Nelsen, and Jim Tananbaum team up with Bit Bio to uncover the “operating system of life” and accelerate the company’s drive towards industrial-scale manufacturing of all human cells CAMBRIDGE  — Bit Bio, a Cambridge-based synthetic biology company combining data science and biology to code cells for the wellb eing of humanity, today announces the close […]

BioFlyte devices are designed to protect the world’s most critical facilities ALBUQUERQUE, N.M. — BioFlyte, a biodefense company created to commercialize a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, announced that it raised $1.25 million in new funding. This seed stage equity financing round was led by venture capital firm […]

BRANFORD, Conn. — Isoplexis, the leader in functional single cell proteomics, announced today that it has been awarded a Phase 2 Small Business Innovation Research (SBIR) grant from the National Institute on Aging of the National Institutes of Health for $2 million to continue analyzing the highly multiplexed proteomic responses of trafficking leukocytes in patients with Alzheimer’s disease, neuroinflammation, […]

Cambridge, UK — Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications – today announced the successful closure of a £1.5M series A investment round to accelerate the global scale-up of its commercial operations and make key hires to its leadership team. The funding round attracted support from a […]